FBLG – fibrobiologics, inc. (US:NASDAQ)
Stock Stats
News
FibroBiologics (FBLG) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $7.00 price target on the stock.
FibroBiologics Announces Advances in Burn Treatment Using Proprietary Fibroblast Spheroid Technology
FibroBiologics Completes Site Onboarding for Phase 1/2 Clinical Trial for CYWC628 for the Treatment of Refractory Diabetic Foot Ulcers
FibroBiologics, Inc. Announces Issuance of U.S. Patent Covering Fibroblast Cell Therapy for the Treatment of Osteoporosis
FibroBiologics to Present at the BIO Investment & Growth Summit
Form 10-K/A FibroBiologics, Inc. For: Dec 31
Form 8-K FibroBiologics, Inc. For: Mar 04
Form 4 FibroBiologics, Inc. For: Mar 04 Filed by: Khoja Hamid
Form 4 FibroBiologics, Inc. For: Mar 02 Filed by: O'HEERON PETE
Form 4 FibroBiologics, Inc. For: Mar 02 Filed by: Davis Jason
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.